News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Industry News Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers May 11, 2017
News Industry News Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 28, 2017